Sales rise 43.76% to Rs 1095.43 crore
Net profit of Alembic Pharmaceuticals rose 105.62% to Rs 251.06 crore in the quarter ended September 2018 as against Rs 122.10 crore during the previous quarter ended September 2017. Sales rose 43.76% to Rs 1095.43 crore in the quarter ended September 2018 as against Rs 762.01 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales1095.43762.01 44 OPM %31.8623.18 -PBDT346.24184.16 88 PBT320.04158.53 102 NP251.06122.10 106Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
